M. Polak

Are myelodysplastic syndromes underdiagnosed in Poland? A report by the Polish Adult Leukaemia Group

W. Wiktor-Jedrzejczak, J. Drozd-Sokołowska, K. Mądry, 2017, European journal of haematology.

LBA35 Phase II study of PARP inhibitor talazoparib and PD-L1 inhibitor avelumab in patients (pts) with microsatellite stable (MSS) recurrent/persistent endometrial cancer

Cesar M. Castro, S. Cannistra, U. Matulonis, 2020 .